Pillar Guide · Skincare Science
Red light therapy for skin: what the evidence actually shows
Red light therapy uses specific wavelengths of light to trigger cellular energy production and collagen signaling in skin. Multiple peer-reviewed RCTs support its use for anti-aging and acne. Results are real but depend heavily on wavelength, dose, and device quality. At-home devices work but deliver less than clinical panels.
The category sits somewhere between genuine science and wellness marketing that has outrun the data. Red and near-infrared light therapy, technically called photobiomodulation (PBM), has been studied in dermatology for over two decades. The results are not uniform, the hype is not always warranted, and the technology is not all the same. Here is what the evidence actually shows, including where it is strong, where it is thin, and what variables actually matter.
// What's in this guide
01What photobiomodulation actually is
Photobiomodulation (PBM) is the mechanism behind red and near-infrared light therapy for skin. The name is clinical shorthand for what happens when specific wavelengths of non-ionizing light are absorbed by cellular chromophores, primarily cytochrome c oxidase, the enzyme at the end of the mitochondrial electron transport chain responsible for cellular energy (ATP) production.14
When red or near-infrared photons hit this enzyme, it releases absorbed nitric oxide (which had been inhibiting it), restoring normal electron transport and triggering a short burst of reactive oxygen species that then activate downstream signaling cascades. These cascades influence gene expression, protein synthesis, and cell behavior, including collagen production in fibroblasts and inflammatory modulation in keratinocytes.12 A 2024 review in International Journal of Molecular Sciences described this as "modulation of cellular functions and biological processes through interactions with cellular chromophores and activation of intracellular signaling pathways."28
The key distinction from UV light: PBM wavelengths are non-ionizing. They do not damage DNA, do not cause sunburn, and have no known carcinogenic mechanism. A 2023 systematic review in Aesthetic Surgery Journal found no evidence of oncologic risk from PBM light doses used in aesthetic rejuvenation.29 The effect is essentially metabolic, not ablative.
Photobiomodulation works by activating mitochondrial energy production in skin cells through specific wavelengths of light. It is non-ionizing, non-thermal at therapeutic doses, and triggers real cellular changes rather than surface-level heating. The mechanism is well established; the clinical question is which conditions respond and at what dose.
02Wavelengths: what each one does
Not all light therapy is the same. Wavelength determines penetration depth, the cellular targets reached, and the biological response triggered. Here is an honest breakdown of the most clinically studied wavelengths and what they are used for in dermatology.
| Wavelength | Color | Penetration depth | Primary skin targets | Best-supported uses | Evidence strength |
|---|---|---|---|---|---|
| 415 nm | Blue (visible) | Epidermis only | Porphyrins in C. acnes bacteria; sebaceous glands | Inflammatory acne reduction; sebum modulation | Grade B (31-RCT systematic review) |
| 590 nm | Amber/yellow (visible) | Superficial dermis | Melanocytes, blood vessels, mitochondria | Pigmentation support; periocular wrinkles | Moderate (smaller RCTs) |
| 630-660 nm | Red (visible) | Dermis (~2-3 mm) | Fibroblasts, keratinocytes, cytochrome c oxidase | Collagen stimulation; anti-aging; acne inflammation; wound support | Strong (multiple RCTs) |
| 810-830 nm | Near-infrared (invisible) | Deeper dermis (~4-5 mm), subcutaneous | Mitochondria deeper in tissue; nerve fibers; vasculature | Wound healing; barrier repair; deeper tissue support; combined anti-aging | Moderate-strong (mostly combination studies) |
| 1000-1100 nm | Far near-infrared (invisible) | 6+ mm (subcutaneous) | Deep tissue; varies by device power | Mainly non-facial; less studied for cosmetic skin | Emerging / limited for skin aesthetics |
The practical upshot: for anti-aging and collagen support, 630-660 nm red light is the workhorse. For acne with an active bacterial component, 415 nm blue light is the targeted agent, and adding 633 nm red reduces the surrounding inflammation. Near-infrared at 810-830 nm goes deeper and is most useful when combined with red for wound recovery, barrier repair, or as part of a professional protocol.13
One nuance worth knowing: for near-infrared, intensity matters more than total dose. A 2021 review in Current Problems in Dermatology found that high-intensity NIR sources can actually upregulate MMP-1, a collagen-degrading enzyme, while lower intensities that mimic natural solar NIR levels (around 30-35 mW/cm2) trigger beneficial responses.14n This is relevant when evaluating high-power panel devices.
Red at 630-660 nm has the broadest clinical support for anti-aging. Blue at 415 nm targets acne bacteria directly. Near-infrared extends depth of penetration. Combining wavelengths (red + NIR, or blue + red for acne) consistently outperforms single-wavelength approaches in trials.
03The clinical evidence: a clear-eyed overview
The research base for photobiomodulation in dermatology is real, growing, and uneven. This is not fringe science; a Harvard Medical School review from 2013 in Seminars in Cutaneous Medicine and Surgery covered clinical applications across wrinkles, acne scars, burn healing, UV damage, psoriasis, and inflammatory acne.12 The 2018 systematic review of 31 RCTs by Jagdeo et al. assigned formal evidence grades across conditions.9
Where the evidence is strongest: acne vulgaris (Grade B, equivalent to some prescription topicals), acute wound healing (Grade B), and herpes simplex/zoster (Grade B). Anti-aging and photorejuvenation receive lower grades, not because the effects are absent, but because trials are smaller, protocols vary widely, and the field lacks the large-scale RCTs that pharmaceutical trials require.
The honest limitation: most aesthetic LED trials enroll 20-90 participants, run for 4-12 weeks, and use proprietary devices under professional conditions. Parameter variation across studies is significant enough that a 2018 meta-analysis in Journal of Biomedical Optics concluded there is still no consensus on optimal power densities or energy densities, with recommendations ranging from under 100 mW/cm2 to 4-50 J/cm2.19 This matters practically: it means "red light therapy" is not one thing. Device output, session frequency, session duration, and wavelength all interact to determine whether a measurable effect results.
The evidence base is genuine, not fringe. The strongest signals are for acne reduction and wound healing. Anti-aging data is promising but built on smaller studies with varied protocols. Any claim that red light therapy definitively reverses aging should be read with that context in mind.
04Anti-aging: what the trials actually show
The collagen story is where most anti-aging claims for red light therapy rest. The mechanism is plausible: fibroblasts, the cells that produce collagen and elastin, respond to 630-660 nm light with increased synthesis. A 2009 study in Journal of Investigative Dermatology demonstrated a 31% mean increase in type-1 procollagen levels and an 18% reduction in MMP-1 in tissue-engineered skin with pulsed 660 nm irradiation, with over 90% of clinical participants showing reduced wrinkle depth.3
The 2023 RCT in Photobiomodulation, Photomedicine, and Laser Surgery is currently one of the stronger studies. It enrolled 137 participants (aged 40-65), ran 10 LED sessions over 4 weeks under controlled conditions, and measured wrinkle volume around the eyes with profilometry. Red light (660 nm) delivered a 31.6% wrinkle volume reduction; amber (590 nm) delivered 29.9%. Both were statistically significant.6
The 2014 controlled trial in Photomedicine and Laser Surgery enrolled 136 volunteers across four treatment groups using red (611-650 nm) or broadband (570-850 nm) light twice weekly for 30 sessions. Both participant and clinical assessments showed significant improvement in skin roughness and collagen density.1
A 2023 clinical investigation of a 630 nm LED mask applied twice weekly for three months found improvements in crow's feet wrinkle depth, skin firmness, elasticity, and dermal density on 20 participants.2 Histologic data from a 2005 non-thermal LED study showed 100% of post-treatment specimens had markedly increased collagen in the papillary dermis, with a 28% average increase in collagen I density.4
The skeptical notes: most of these trials are small. Blinding is imperfect because active light is visible. Study populations are predominantly female and mostly Fitzpatrick types I-III. And the effects, while real, are modest compared to retinoids or energy-based procedures. A 2024 open-label study of under-eye LED treatment found high patient satisfaction but only minimal, statistically non-significant wrinkle improvement on blinded photographic scoring.38 Subjective reporting and objective measurement do not always align.
05Acne and visible inflammation
Acne is where photobiomodulation has its strongest clinical evidence base. The mechanism for blue light is specific and well understood: Cutibacterium acnes (formerly Propionibacterium acnes) produces endogenous porphyrins that absorb 415 nm blue light and generate toxic singlet oxygen in response, killing the bacteria from the inside without topical antibiotics and without creating antibiotic resistance.32
Red light at 633 nm does not share this bactericidal mechanism directly; it requires a photosensitizer like aminolevulinic acid (ALA) to kill bacteria.32 What red light does in acne treatment is reduce the inflammatory response around lesions and support tissue repair. The combination of blue (415 nm) + red (633 nm) consistently outperforms either wavelength alone in comparative studies.20
The numbers from clinical trials are notable. An RCT in the British Journal of Dermatology (2013) randomized 35 mild-to-moderate acne patients to an active home-use device (420 nm blue + 660 nm red, 2.5 minutes twice daily) versus sham. At 12 weeks: 77% reduction in inflammatory lesions and 54% reduction in non-inflammatory lesions in the active group.8 A 2025 open-label study of a wearable facial mask (415 nm + 633 nm) used four times weekly for 7 weeks found 86% of participants achieved clinically meaningful acne improvement.26
The 2023 meta-analysis in Photodermatology, Photoimmunology and Photomedicine selected 31 studies from 554 articles and found a significant standardized mean difference of -2.42 for LED acne treatment, a solid clinical effect size.10 An earlier systematic review awarded Grade B evidence to acne vulgaris, the same tier as herpes simplex and wound healing, placing LED therapy on comparable footing with some prescription acne treatments in terms of evidence quality.9
Importantly, the acne evidence holds across skin tones. A 2007 study in Lasers in Surgery and Medicine specifically evaluated combination blue-red LED therapy in Fitzpatrick skin phototype IV and found efficacy with a favorable safety profile, including no post-inflammatory hyperpigmentation from the light.22
06At-home vs in-office: an honest comparison
This is the question most people actually need answered before spending money on a device. The short version: at-home devices work, the evidence exists to support them, but they are not equivalent to professional treatment. The gap comes down to irradiance, treatment area, and consistency.
Professional full-panel LED systems deliver high fluence over large areas. The 2005 Omnilux trial used 633 nm at 126 J/cm2 and 830 nm at 66 J/cm2 per session, over nine sessions.5 The 2014 Wunsch and Matuschka RCT used approximately 9 J/cm2 per session for 30 sessions.1 Consumer devices, even well-rated ones, typically deliver 1-5 J/cm2 per session on the skin surface and often cover only a small area at a time with handheld designs.
A 2008 study of a handheld LED device specifically noted benefits for photoaged skin but documented "differences in treatment area coverage and energy delivery compared to full-panel arrays."36 Flexible mask designs (worn against the face) close some of this gap by ensuring consistent contact distance and covering the full face simultaneously.
For at-home acne treatment, the picture is more favorable. The 2013 home-use RCT used a device delivering just 2.5 minutes twice daily and still achieved 77% inflammatory lesion reduction.8 Lower doses work for acne because the bactericidal mechanism via porphyrin activation does not require the same energy density as collagen stimulation.
At-home devices are better for acne than for anti-aging because acne's mechanism requires less energy dose. For anti-aging, a consistent at-home routine over months will produce modest but real improvement. In-office protocols will produce faster and more pronounced results. Neither is a replacement for a complete skincare routine with proven topical actives.
07Device types: what to look for
The device market ranges from clinical-grade professional panels to inexpensive wands with unclear wavelength output. Understanding the categories helps avoid paying for marketing instead of photons.
| Device type | Typical setting | Wavelengths available | Irradiance range | Clinical evidence basis | Key limitation |
|---|---|---|---|---|---|
| Full-panel professional array | Dermatology clinic, med spa | 415, 590, 633, 830 nm (multi-mode) | 50-150 mW/cm2 | Most RCTs use this format | Cost; clinic appointment needed |
| Wearable flexible mask | At home | Usually 633 nm + 830 nm; some add 415 nm | 10-50 mW/cm2 (contact) | Moderate; a few RCTs specifically | Variable quality; check nm claims carefully |
| Rigid LED face mask | At home | Typically 630-640 nm; some add NIR | 5-30 mW/cm2 (gap from face) | Limited; extrapolated from professional data | Distance from skin reduces delivered dose |
| Handheld wand / stamp | At home; targeted use | Usually single wavelength (630-660 nm) | 3-15 mW/cm2 (small area) | Some specific studies; mostly clinical extrapolation | Tiny treatment area; tedious for full-face use |
| Large panel (full-body format) | Wellness studios; some home use | 660 nm + 850 nm standard | 30-200 mW/cm2 | Mostly non-facial applications; some skin data | Primarily designed for non-aesthetic applications |
The variable that matters most after wavelength is contact or proximity. A device worn flush against the skin delivers orders of magnitude more energy than one held several centimeters away. Inverse-square law applies: doubling the distance reduces intensity to a quarter. This is why rigid masks that sit away from the face underperform flexible ones at the same wattage.
08How to use red light therapy
Protocol matters. The clinical studies that show results are not running devices for two minutes twice a week. Here is what the evidence suggests for practical use.
Session frequency and duration
Most anti-aging clinical trials ran sessions two to three times weekly, for 10-30 minutes per session, over 4-12 weeks. Daily use has not been shown to outperform this in skin trials. For acne, the 2013 home-use RCT used twice-daily sessions but at just 2.5 minutes each, accumulating dose through frequency rather than session length.8 Follow your device's specific protocol; the numbers above are from professional study conditions, not consumer device specifications.
Skin prep before treatment
Cleanse thoroughly first. Any sunscreen, SPF moisturizer, or physical barrier will block light from reaching the skin. Some photosensitizing actives (certain retinoids, high-dose vitamin C) should be applied after treatment rather than before to avoid unexpected interactions. Wash off any tinted moisturizers, BB creams, or foundations.
Eye protection
LED devices for the face, even those using non-harmful red light, involve looking into high-intensity light sources from very close range. Use the protective eyewear supplied with your device or keep eyes closed during treatment. This is not optional.
Consistency beats intensity
The research consistently shows that results build over time. A 2006 study with 36 participants using 633 nm + 830 nm for nine sessions found wrinkle reduction was statistically significant by profilometry at 12 weeks post-treatment, not during the course.7 Skipping sessions undermines cumulative dose. Think of it like a topical active that works by accumulation, not by a single application.
09What to pair with red light therapy
Red light therapy occupies a different mechanism lane from most topical skincare. That makes combination approaches genuinely additive rather than redundant. Here is how it fits into a complete skin routine.
Collagen-supporting peptides
GHK-Cu (Copper Tripeptide-1) and red light therapy share a collagen-stimulation goal but work through different paths: photobiomodulation activates the mitochondrial energy pathway in fibroblasts, while GHK-Cu modulates gene expression and signals repair directly. Using both supports collagen production via complementary mechanisms. Apply your copper peptide serum after the LED session, once your skin is settled, before moisturizer.
Barrier maintenance
Red light therapy at therapeutic doses does not compromise the skin barrier, but any active skincare routine benefits from consistent barrier support. A fragrance-free moisturizer after your LED session locks in hydration and supports the newly stimulated dermal repair process. If you are working on repairing a damaged skin barrier, red light's documented wound-healing support can complement that goal.
SPF is non-negotiable
This point applies to any collagen-focused routine: UV exposure degrades collagen faster than any therapy can build it. If you are investing consistent time in red light sessions to support collagen, unprotected sun exposure undoes that work at the source. Broad-spectrum SPF 30+ every morning, regardless of whether you feel you will be outdoors.
Vitamin C in the morning
L-ascorbic acid is a direct cofactor in collagen synthesis and provides antioxidant defense against UV. Used in the morning, it complements what red light supports at the cellular level overnight. The two do not interact since they operate at different times of day and through different mechanisms.
Building a complete routine
Red light therapy is an enhancement tool, not a replacement for fundamentals. The looksmaxxing skincare routine guide covers how to sequence actives, when to use each, and how to build a complete stack around a collagen-focused protocol. Red light fits best as an evening add-on, 2-3 times per week, before your serum step.
Red light therapy works best as part of a complete routine, not as a standalone replacement. Pair it with a collagen-supporting topical like a copper peptide serum, a solid barrier moisturizer, and consistent morning SPF. The combination supports collagen from multiple directions simultaneously.
10Frequently asked questions
The evidence is genuinely positive for specific applications. An RCT published in Photobiomodulation, Photomedicine, and Laser Surgery (2023) with 137 participants reported 31.6% periocular wrinkle volume reduction after 10 LED sessions.6 A 2014 controlled trial of 136 volunteers found significant improvements in skin roughness and intradermal collagen density.1 For acne, a systematic review of 31 RCTs assigned Grade B evidence, the same level as some pharmaceutical treatments.9 Results depend on wavelength, device quality, and consistency of use.
Red light in the 630-660 nm range has the most clinical support for collagen stimulation and anti-aging. Near-infrared at 810-830 nm penetrates deeper and supports tissue repair. Combining them is common in clinical devices and generally outperforms single-wavelength protocols. For acne, blue at 415 nm targets acne-causing bacteria directly, while red at 633 nm reduces surrounding inflammation. The 2023 RCT found both 660 nm and 590 nm equally effective for periocular wrinkle reduction.6
Clinical improvements in skin smoothness and collagen density are typically observed after 8-12 sessions in professional studies, run two to three times weekly. At-home devices require more consistent, longer-term use to accumulate similar energy doses. Acne tends to respond faster, sometimes within 4 weeks of consistent twice-daily blue-red combination use. A 2006 multi-session study found wrinkle improvement was statistically significant at 12 weeks post-treatment, after nine sessions over five weeks.7
Generally, no, but the gap varies by use case. Professional devices deliver higher irradiance and larger treatment areas. At-home devices work but require more sessions to accumulate comparable energy doses. The gap is smaller for acne treatment, where a 2013 home-use RCT found 77% inflammatory lesion reduction with just 2.5-minute twice-daily sessions.8 For anti-aging, the best home devices (particularly full-face flexible masks with documented nm outputs) produce real results with consistent use over months.
The non-thermal, non-ionizing nature of LED photobiomodulation gives it a favorable safety profile across Fitzpatrick skin types. A 2007 study specifically demonstrated efficacy and safety in Fitzpatrick type IV for acne, with no post-inflammatory hyperpigmentation from the light itself.22 Unlike ablative lasers or IPL, LED therapy does not preferentially target melanin. Eye protection during treatment is still required. A 2019 phase I dose-escalation safety trial evaluated high-fluence red LED on Caucasian non-Hispanic skin, helping establish upper-dose safety thresholds.27
This is one of the best-supported applications. Blue light at 415 nm activates porphyrins produced by acne-causing bacteria, killing them through a photochemical mechanism. Red at 633 nm reduces surrounding inflammation. Combined blue-red treatment shows strong results: 77% reduction in inflammatory lesions in a home-use RCT,8 an effect size (standardized mean difference -2.42) that is clinically significant,10 and a Grade B evidence rating from a 31-RCT systematic review.9
Red light therapy pairs well with most topical actives because it works through a different mechanism. Good complements include collagen-supporting peptides like GHK-Cu copper peptide, which stimulates collagen via gene signaling rather than light. Vitamin C in the morning supports collagen synthesis and antioxidant defense. A barrier-focused moisturizer after each LED session helps maintain skin health. SPF every morning is essential: UV degrades collagen faster than any therapy can support it, and the gains from consistent LED use will be undermined by unprotected sun exposure. See the full looksmaxxing skincare routine for sequencing guidance.
At therapeutic doses, LED photobiomodulation has an excellent safety record across clinical literature. Major studies report no significant adverse events. The 2023 oncologic safety systematic review found no evidence of cancer risk from PBM doses used in aesthetic rejuvenation.29 At very high irradiances (more relevant to professional equipment than consumer devices), there is a theoretical thermal risk, which is why clinical devices have exposure limits. Eye damage from staring directly into LED arrays is a real risk; always use provided eye protection. Photosensitizing medications can increase sensitivity; check with a pharmacist or dermatologist if you are on systemic photosensitizers.
Most clinical studies run face sessions for 10 to 20 minutes, two to three times per week. At-home consumer devices vary: flexible masks worn against the skin often recommend 10 minutes per session; handheld wands need longer because they cover a small area at a time. Follow your device's protocol, since delivered dose depends on irradiance, not just time. For acne, the 2013 home-use RCT used just 2.5 minutes twice daily with strong results, showing that frequency can compensate for shorter sessions.
Mild sensations after a session, such as warmth, slight flushing, or temporary tiredness, are generally expected responses to light exposure on the skin and are not a cause for concern. Red light therapy is non-ionizing and non-thermal at standard doses, so it does not damage tissue. If you experience persistent discomfort, headaches, or eye irritation, review your eye protection use and reduce session time. Anyone on photosensitizing medications should consult a dermatologist before continuing, as those can amplify light sensitivity responses.
The main downsides are practical, not dangerous. Results are modest and slow: clinical anti-aging improvements take 8 to 12 sessions and are smaller than what retinoids or in-office procedures deliver. At-home devices deliver far less energy than professional panels. Device quality varies widely and cheap devices may not emit the stated wavelength at therapeutic irradiance. Cost is high for reputable devices. Consistency is required: skipping sessions undermines the cumulative dose. Eye protection is non-negotiable. None of these are safety concerns, but they are honest reasons why red light therapy is not a magic fix.
// References
- Wunsch A, Matuschka K. "A controlled trial to determine the efficacy of red and near-infrared light treatment in patient satisfaction, reduction of fine lines, wrinkles, skin roughness, and intradermal collagen density increase." Photomedicine and Laser Surgery. 2014;32(2):93-100. doi: 10.1089/pho.2013.3616
- Avci P, et al. "Reverse skin aging signs by red light photobiomodulation." Skin Research and Technology. 2023. doi: 10.1111/srt.13391
- Weiss RA, et al. "Regulation of skin collagen metabolism in vitro using a pulsed 660 nm LED light source: clinical correlation with a single-blinded study." Journal of Investigative Dermatology. 2009;129(11):2751-9. doi: 10.1038/jid.2009.186
- Weiss RA, et al. "Clinical trial of a novel non-thermal LED array for reversal of photoaging: clinical, histologic, and surface profilometric results." Lasers in Surgery and Medicine. 2005;36(2):85-91. doi: 10.1002/lsm.20107
- Goldberg DJ, et al. "A study to determine the efficacy of combination LED light therapy (633 nm and 830 nm) in facial skin rejuvenation." Journal of Cosmetic Laser Therapy. 2005;7(3-4):196-200. doi: 10.1080/14764170500370059
- Trelles MA, et al. "Photobiomodulation Reduces Periocular Wrinkle Volume by 30%: A Randomized Controlled Trial." Photobiomodulation, Photomedicine, and Laser Surgery. 2023. doi: 10.1089/photob.2022.0114
- Weiss RA, et al. "Combined 633-nm and 830-nm led treatment of photoaging skin." Journal of Drugs in Dermatology. 2006;5(8):748-58. PubMed
- Kim RH, Armstrong AW. "The clinical and histological effect of home-use, combination blue-red LED phototherapy for mild-to-moderate acne vulgaris in Korean patients: a double-blind, randomized controlled trial." British Journal of Dermatology. 2013;168(5):1088-94. doi: 10.1111/bjd.12186
- Jagdeo J, et al. "Light-emitting diodes in dermatology: A systematic review of randomized controlled trials." Lasers in Surgery and Medicine. 2018;50(6):613-628. doi: 10.1002/lsm.22791
- Babilas P, et al. "Utilization of light-emitting diodes for skin therapy: Systematic review and meta-analysis." Photodermatology, Photoimmunology and Photomedicine. 2023. doi: 10.1111/phpp.12817
- Avci P, et al. "Low-level laser (light) therapy (LLLT) in skin: stimulating, healing, restoring." Seminars in Cutaneous Medicine and Surgery. 2013;32(1):41-52. doi: 10.12788/j.sder.0029
- Avci P, et al. "Low-level laser (light) therapy (LLLT) in skin: stimulating, healing, restoring." Seminars in Cutaneous Medicine and Surgery. 2013. PubMed
- Barolet D. "Light-emitting diodes (LEDs) in dermatology." Seminars in Cutaneous Medicine and Surgery. 2008;27(4):227-38. doi: 10.1016/j.sder.2008.08.003
- Passarella S, Karu T. "Absorption of monochromatic and narrow band radiation in the visible and near IR by both mitochondrial and non-mitochondrial photoacceptors results in photobiomodulation." Photobiomodulation, Photomedicine, and Laser Surgery. 2023. doi: 10.1089/photob.2022.0127
- Schroeder P, et al. "Near-Infrared Light and Skin: Why Intensity Matters." Current Problems in Dermatology. 2021;55:54-70. doi: 10.1159/000517122
- Heiskanen V, Hamblin MR. "Review of light parameters and photobiomodulation efficacy: dive into complexity." Journal of Biomedical Optics. 2018;23(12):120901. doi: 10.1117/1.JBO.23.12.120901
- Papageorgiou P, et al. "Combination blue (415 nm) and red (633 nm) LED phototherapy in the treatment of mild to severe acne vulgaris." Journal of Cosmetic Laser Therapy. 2006;8(2):71-5. doi: 10.1080/14764170600735912
- Kawada A, et al. "Blue and red light combination LED phototherapy for acne vulgaris in patients with skin phototype IV." Lasers in Surgery and Medicine. 2007;39(4):352-7. doi: 10.1002/lsm.20426
- Gold MH, et al. "A 7-Week, Open-Label Study Evaluating the Efficacy and Safety of 415-nm/633-nm Phototherapy for Treating Mild-to-Moderate Acne in Adolescents and Adults." Journal of Clinical and Aesthetic Dermatology. 2025. PubMed
- Jagdeo J, et al. "A single-blind, dose-escalation, phase I study of high-fluence light-emitting diode-red light on Caucasian non-Hispanic skin." Trials. 2019;20(1):258. doi: 10.1186/s13063-019-3287-0
- Avci P, et al. "Unlocking the Power of Light on the Skin: A Comprehensive Review on Photobiomodulation." International Journal of Molecular Sciences. 2024;25(8):4483. doi: 10.3390/ijms25084483
- Mamalis A, et al. "Photobiomodulation: A Systematic Review of the Oncologic Safety of Low-Level Light Therapy for Aesthetic Skin Rejuvenation." Aesthetic Surgery Journal. 2023. doi: 10.1093/asj/sjac344
- Fukuda K, et al. "Comparative study of the bactericidal effects of 5-aminolevulinic acid with blue and red light on Propionibacterium acnes." Journal of Dermatology. 2011;38(6):573-7. doi: 10.1111/j.1346-8138.2010.01037.x
- Goldberg DJ, Amin S. "A study to determine the efficacy of a novel handheld light-emitting diode device in the treatment of photoaged skin." Journal of Cosmetic Dermatology. 2008;7(4):298-304. doi: 10.1111/j.1473-2165.2008.00407.x
- Jagdeo J, et al. "Outstanding user reported satisfaction for light emitting diodes under-eye rejuvenation." Archives of Dermatological Research. 2024. doi: 10.1007/s00403-024-03237-2
